SEC Form 4 · accession 0001209191-16-156372
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ashraf Amanullah
Officer — Vice President, Manufacturing
Period of report
Dec 20, 2016
Accepted (ET)
Dec 21, 2016 · 6:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 20, 2016 | P | 11,000 | $2.2499 | A | 11,000 | D |
Table II — derivative securities
No Table II lines on this filing.